UniProt ID | P66A_HUMAN | |
---|---|---|
UniProt AC | Q86YP4 | |
Protein Name | Transcriptional repressor p66-alpha | |
Gene Name | GATAD2A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 633 | |
Subcellular Localization | Nucleus speckle . Speckled nuclear localization requires both CR1 and CR2 regions. | |
Protein Description | Transcriptional repressor. Enhances MBD2-mediated repression. Efficient repression requires the presence of GATAD2B.. | |
Protein Sequence | MTEEACRTRSQKRALERDPTEDDVESKKIKMERGLLASDLNTDGDMRVTPEPGAGPTQGLLRATEATAMAMGRGEGLVGDGPVDMRTSHSDMKSERRPPSPDVIVLSDNEQPSSPRVNGLTTVALKETSTEALMKSSPEERERMIKQLKEELRLEEAKLVLLKKLRQSQIQKEATAQKPTGSVGSTVTTPPPLVRGTQNIPAGKPSLQTSSARMPGSVIPPPLVRGGQQASSKLGPQASSQVVMPPLVRGAQQIHSIRQHSSTGPPPLLLAPRASVPSVQIQGQRIIQQGLIRVANVPNTSLLVNIPQPTPASLKGTTATSAQANSTPTSVASVVTSAESPASRQAAAKLALRKQLEKTLLEIPPPKPPAPEMNFLPSAANNEFIYLVGLEEVVQNLLETQGRMSAATVLSREPYMCAQCKTDFTCRWREEKSGAIMCENCMTTNQKKALKVEHTSRLKAAFVKALQQEQEIEQRLLQQGTAPAQAKAEPTAAPHPVLKQVIKPRRKLAFRSGEARDWSNGAVLQASSQLSRGSATTPRGVLHTFSPSPKLQNSASATALVSRTGRHSERTVSAGKGSATSNWKKTPLSTGGTLAFVSPSLAVHKSSSAVDRQREYLLDMIPPRSIPQSATWK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
20 | Phosphorylation | RALERDPTEDDVESK HHHHCCCCHHHHHHH | 57.23 | 23917254 | |
26 | Phosphorylation | PTEDDVESKKIKMER CCHHHHHHHHHHHHC | 38.81 | 22985185 | |
27 | Acetylation | TEDDVESKKIKMERG CHHHHHHHHHHHHCC | 45.04 | 25953088 | |
30 | Sumoylation | DVESKKIKMERGLLA HHHHHHHHHHCCCCH | 43.52 | - | |
30 | Sumoylation | DVESKKIKMERGLLA HHHHHHHHHHCCCCH | 43.52 | - | |
38 | Phosphorylation | MERGLLASDLNTDGD HHCCCCHHHCCCCCC | 42.47 | 29978859 | |
42 | Phosphorylation | LLASDLNTDGDMRVT CCHHHCCCCCCCCCC | 48.97 | 29255136 | |
46 | Sulfoxidation | DLNTDGDMRVTPEPG HCCCCCCCCCCCCCC | 4.55 | 21406390 | |
49 | Phosphorylation | TDGDMRVTPEPGAGP CCCCCCCCCCCCCCC | 16.15 | 19664994 | |
57 | Phosphorylation | PEPGAGPTQGLLRAT CCCCCCCCHHHHHHH | 34.06 | 29978859 | |
64 | Phosphorylation | TQGLLRATEATAMAM CHHHHHHHHHHHHHC | 21.51 | 27251275 | |
67 | Phosphorylation | LLRATEATAMAMGRG HHHHHHHHHHHCCCC | 15.67 | 27251275 | |
73 | Methylation | ATAMAMGRGEGLVGD HHHHHCCCCCCCCCC | 27.23 | - | |
85 | Sulfoxidation | VGDGPVDMRTSHSDM CCCCCCCCCCCHHHC | 5.25 | 21406390 | |
87 | Phosphorylation | DGPVDMRTSHSDMKS CCCCCCCCCHHHCCC | 24.93 | 24719451 | |
88 | Phosphorylation | GPVDMRTSHSDMKSE CCCCCCCCHHHCCCC | 15.61 | 24719451 | |
90 | Phosphorylation | VDMRTSHSDMKSERR CCCCCCHHHCCCCCC | 38.88 | 27251275 | |
93 | Sumoylation | RTSHSDMKSERRPPS CCCHHHCCCCCCCCC | 54.90 | - | |
93 | Sumoylation | RTSHSDMKSERRPPS CCCHHHCCCCCCCCC | 54.90 | 28112733 | |
94 | Phosphorylation | TSHSDMKSERRPPSP CCHHHCCCCCCCCCC | 29.69 | 21406692 | |
100 | Phosphorylation | KSERRPPSPDVIVLS CCCCCCCCCCEEEEC | 36.09 | 29255136 | |
107 | Phosphorylation | SPDVIVLSDNEQPSS CCCEEEECCCCCCCC | 27.74 | 29255136 | |
113 | Phosphorylation | LSDNEQPSSPRVNGL ECCCCCCCCCCCCCE | 53.31 | 29255136 | |
114 | Phosphorylation | SDNEQPSSPRVNGLT CCCCCCCCCCCCCEE | 24.33 | 29255136 | |
121 | Phosphorylation | SPRVNGLTTVALKET CCCCCCEEEEEEEEC | 22.18 | 22115753 | |
122 | Phosphorylation | PRVNGLTTVALKETS CCCCCEEEEEEEECC | 14.61 | 22115753 | |
128 | Phosphorylation | TTVALKETSTEALMK EEEEEEECCHHHHHH | 39.08 | 24732914 | |
129 | Phosphorylation | TVALKETSTEALMKS EEEEEECCHHHHHHC | 25.91 | 21815630 | |
130 | Phosphorylation | VALKETSTEALMKSS EEEEECCHHHHHHCC | 32.47 | 30624053 | |
135 | Ubiquitination | TSTEALMKSSPEERE CCHHHHHHCCHHHHH | 48.94 | - | |
135 | Ubiquitination | TSTEALMKSSPEERE CCHHHHHHCCHHHHH | 48.94 | - | |
136 | Phosphorylation | STEALMKSSPEERER CHHHHHHCCHHHHHH | 36.84 | 24732914 | |
137 | Phosphorylation | TEALMKSSPEERERM HHHHHHCCHHHHHHH | 30.71 | 24732914 | |
153 | Methylation | KQLKEELRLEEAKLV HHHHHHHCHHHHHHH | 43.25 | - | |
158 | Ubiquitination | ELRLEEAKLVLLKKL HHCHHHHHHHHHHHH | 42.27 | - | |
172 | Acetylation | LRQSQIQKEATAQKP HHHHHHHHHHHCCCC | 51.44 | 7366045 | |
175 | Phosphorylation | SQIQKEATAQKPTGS HHHHHHHHCCCCCCC | 30.61 | 21712546 | |
178 | Ubiquitination | QKEATAQKPTGSVGS HHHHHCCCCCCCCCC | 41.92 | - | |
178 | Sumoylation | QKEATAQKPTGSVGS HHHHHCCCCCCCCCC | 41.92 | 28112733 | |
178 | Ubiquitination | QKEATAQKPTGSVGS HHHHHCCCCCCCCCC | 41.92 | - | |
180 | Phosphorylation | EATAQKPTGSVGSTV HHHCCCCCCCCCCEE | 49.47 | 22115753 | |
182 | O-linked_Glycosylation | TAQKPTGSVGSTVTT HCCCCCCCCCCEECC | 26.28 | 30059200 | |
182 | Phosphorylation | TAQKPTGSVGSTVTT HCCCCCCCCCCEECC | 26.28 | 22115753 | |
185 | Phosphorylation | KPTGSVGSTVTTPPP CCCCCCCCEECCCCC | 19.97 | 30266825 | |
186 | Phosphorylation | PTGSVGSTVTTPPPL CCCCCCCEECCCCCC | 18.88 | 30266825 | |
188 | Phosphorylation | GSVGSTVTTPPPLVR CCCCCEECCCCCCCC | 33.40 | 30266825 | |
189 | Phosphorylation | SVGSTVTTPPPLVRG CCCCEECCCCCCCCC | 29.48 | 25159151 | |
204 | Ubiquitination | TQNIPAGKPSLQTSS CCCCCCCCCCCCCCC | 33.27 | - | |
204 | Acetylation | TQNIPAGKPSLQTSS CCCCCCCCCCCCCCC | 33.27 | 26051181 | |
204 | Sumoylation | TQNIPAGKPSLQTSS CCCCCCCCCCCCCCC | 33.27 | 28112733 | |
204 | Ubiquitination | TQNIPAGKPSLQTSS CCCCCCCCCCCCCCC | 33.27 | - | |
206 | Phosphorylation | NIPAGKPSLQTSSAR CCCCCCCCCCCCCCC | 36.27 | 28555341 | |
209 | O-linked_Glycosylation | AGKPSLQTSSARMPG CCCCCCCCCCCCCCC | 29.91 | 30059200 | |
210 | O-linked_Glycosylation | GKPSLQTSSARMPGS CCCCCCCCCCCCCCC | 14.72 | 30059200 | |
211 | Phosphorylation | KPSLQTSSARMPGSV CCCCCCCCCCCCCCC | 24.23 | 20068231 | |
213 | Methylation | SLQTSSARMPGSVIP CCCCCCCCCCCCCCC | 33.50 | - | |
214 | Sulfoxidation | LQTSSARMPGSVIPP CCCCCCCCCCCCCCC | 4.39 | 21406390 | |
217 | Phosphorylation | SSARMPGSVIPPPLV CCCCCCCCCCCCCEE | 15.82 | 22210691 | |
225 | Methylation | VIPPPLVRGGQQASS CCCCCEECCCCCCHH | 51.73 | - | |
233 | Ubiquitination | GGQQASSKLGPQASS CCCCCHHCCCCCCCC | 55.77 | - | |
233 | Acetylation | GGQQASSKLGPQASS CCCCCHHCCCCCCCC | 55.77 | 25953088 | |
233 | Sumoylation | GGQQASSKLGPQASS CCCCCHHCCCCCCCC | 55.77 | 28112733 | |
233 | Ubiquitination | GGQQASSKLGPQASS CCCCCHHCCCCCCCC | 55.77 | - | |
239 | Phosphorylation | SKLGPQASSQVVMPP HCCCCCCCCCCCCCC | 18.96 | 26714015 | |
240 | Phosphorylation | KLGPQASSQVVMPPL CCCCCCCCCCCCCCC | 29.97 | 26714015 | |
244 | Sulfoxidation | QASSQVVMPPLVRGA CCCCCCCCCCCCCCH | 2.73 | 21406390 | |
249 | Dimethylation | VVMPPLVRGAQQIHS CCCCCCCCCHHHHHH | 42.27 | - | |
249 | Methylation | VVMPPLVRGAQQIHS CCCCCCCCCHHHHHH | 42.27 | 24129315 | |
256 | Phosphorylation | RGAQQIHSIRQHSST CCHHHHHHHHHCCCC | 22.54 | 23401153 | |
258 | Dimethylation | AQQIHSIRQHSSTGP HHHHHHHHHCCCCCC | 31.04 | - | |
258 | Methylation | AQQIHSIRQHSSTGP HHHHHHHHHCCCCCC | 31.04 | 24129315 | |
261 | Phosphorylation | IHSIRQHSSTGPPPL HHHHHHCCCCCCCCE | 22.66 | 23312004 | |
262 | Phosphorylation | HSIRQHSSTGPPPLL HHHHHCCCCCCCCEE | 34.95 | 23312004 | |
263 | Phosphorylation | SIRQHSSTGPPPLLL HHHHCCCCCCCCEEE | 57.64 | 23312004 | |
273 | Dimethylation | PPLLLAPRASVPSVQ CCEEECCCCCCCCEE | 33.61 | - | |
273 | Methylation | PPLLLAPRASVPSVQ CCEEECCCCCCCCEE | 33.61 | 24129315 | |
275 | Phosphorylation | LLLAPRASVPSVQIQ EEECCCCCCCCEEEC | 35.52 | 29978859 | |
278 | Phosphorylation | APRASVPSVQIQGQR CCCCCCCCEEECCEE | 25.21 | 23186163 | |
285 | Methylation | SVQIQGQRIIQQGLI CEEECCEEHHHCCCE | 34.50 | 24129315 | |
293 | Methylation | IIQQGLIRVANVPNT HHHCCCEEEECCCCC | 26.91 | - | |
300 | Phosphorylation | RVANVPNTSLLVNIP EEECCCCCEEEEECC | 18.06 | 28122231 | |
301 | Phosphorylation | VANVPNTSLLVNIPQ EECCCCCEEEEECCC | 26.75 | 28122231 | |
310 | Phosphorylation | LVNIPQPTPASLKGT EEECCCCCCCCCCCC | 26.66 | 28122231 | |
313 | Phosphorylation | IPQPTPASLKGTTAT CCCCCCCCCCCCCCC | 31.64 | 20068231 | |
317 | O-linked_Glycosylation | TPASLKGTTATSAQA CCCCCCCCCCCCCCC | 16.21 | 30059200 | |
317 | Phosphorylation | TPASLKGTTATSAQA CCCCCCCCCCCCCCC | 16.21 | 24732914 | |
318 | O-linked_Glycosylation | PASLKGTTATSAQAN CCCCCCCCCCCCCCC | 36.28 | 30059200 | |
318 | Phosphorylation | PASLKGTTATSAQAN CCCCCCCCCCCCCCC | 36.28 | 24732914 | |
320 | Phosphorylation | SLKGTTATSAQANST CCCCCCCCCCCCCCC | 23.62 | 24732914 | |
321 | O-linked_Glycosylation | LKGTTATSAQANSTP CCCCCCCCCCCCCCC | 18.87 | 30059200 | |
321 | Phosphorylation | LKGTTATSAQANSTP CCCCCCCCCCCCCCC | 18.87 | 24732914 | |
326 | O-linked_Glycosylation | ATSAQANSTPTSVAS CCCCCCCCCCCCHHH | 38.49 | 30059200 | |
326 | Phosphorylation | ATSAQANSTPTSVAS CCCCCCCCCCCCHHH | 38.49 | 24732914 | |
327 | O-linked_Glycosylation | TSAQANSTPTSVASV CCCCCCCCCCCHHHH | 30.32 | 30059200 | |
327 | Phosphorylation | TSAQANSTPTSVASV CCCCCCCCCCCHHHH | 30.32 | 25159151 | |
329 | O-linked_Glycosylation | AQANSTPTSVASVVT CCCCCCCCCHHHHHH | 35.60 | 30059200 | |
329 | Phosphorylation | AQANSTPTSVASVVT CCCCCCCCCHHHHHH | 35.60 | 28176443 | |
330 | O-linked_Glycosylation | QANSTPTSVASVVTS CCCCCCCCHHHHHHC | 19.52 | 30059200 | |
330 | Phosphorylation | QANSTPTSVASVVTS CCCCCCCCHHHHHHC | 19.52 | 29255136 | |
333 | O-linked_Glycosylation | STPTSVASVVTSAES CCCCCHHHHHHCCCC | 18.24 | 30059200 | |
333 | Phosphorylation | STPTSVASVVTSAES CCCCCHHHHHHCCCC | 18.24 | 29255136 | |
336 | O-linked_Glycosylation | TSVASVVTSAESPAS CCHHHHHHCCCCHHH | 21.77 | 30059200 | |
336 | Phosphorylation | TSVASVVTSAESPAS CCHHHHHHCCCCHHH | 21.77 | 29255136 | |
337 | Phosphorylation | SVASVVTSAESPASR CHHHHHHCCCCHHHH | 20.59 | 29255136 | |
340 | Phosphorylation | SVVTSAESPASRQAA HHHHCCCCHHHHHHH | 26.03 | 29255136 | |
343 | O-linked_Glycosylation | TSAESPASRQAAAKL HCCCCHHHHHHHHHH | 28.45 | 30059200 | |
343 | Phosphorylation | TSAESPASRQAAAKL HCCCCHHHHHHHHHH | 28.45 | 29255136 | |
349 | Ubiquitination | ASRQAAAKLALRKQL HHHHHHHHHHHHHHH | 29.57 | - | |
404 | Sulfoxidation | LLETQGRMSAATVLS HHHHCCCCCHHHHHC | 4.01 | 21406390 | |
405 | Phosphorylation | LETQGRMSAATVLSR HHHCCCCCHHHHHCC | 17.25 | 20068231 | |
411 | Phosphorylation | MSAATVLSREPYMCA CCHHHHHCCCCEEEC | 30.20 | 20068230 | |
421 | Ubiquitination | PYMCAQCKTDFTCRW CEEECCCCCCCCCCC | 38.76 | - | |
422 | Ubiquitination | YMCAQCKTDFTCRWR EEECCCCCCCCCCCC | 43.93 | - | |
432 | Acetylation | TCRWREEKSGAIMCE CCCCCHHCCCCEEEE | 49.81 | 26051181 | |
432 | Ubiquitination | TCRWREEKSGAIMCE CCCCCHHCCCCEEEE | 49.81 | - | |
451 | Sumoylation | TNQKKALKVEHTSRL CCHHHCCCCHHHHHH | 50.89 | - | |
451 | Sumoylation | TNQKKALKVEHTSRL CCHHHCCCCHHHHHH | 50.89 | - | |
452 | Ubiquitination | NQKKALKVEHTSRLK CHHHCCCCHHHHHHH | 7.29 | - | |
455 | Phosphorylation | KALKVEHTSRLKAAF HCCCCHHHHHHHHHH | 11.31 | 20068231 | |
456 | Phosphorylation | ALKVEHTSRLKAAFV CCCCHHHHHHHHHHH | 37.21 | 20068231 | |
464 | Sumoylation | RLKAAFVKALQQEQE HHHHHHHHHHHHHHH | 36.60 | 28112733 | |
464 | Ubiquitination | RLKAAFVKALQQEQE HHHHHHHHHHHHHHH | 36.60 | 21890473 | |
464 (in isoform 1) | Ubiquitination | - | 36.60 | 21890473 | |
464 (in isoform 2) | Ubiquitination | - | 36.60 | 21890473 | |
465 | Ubiquitination | LKAAFVKALQQEQEI HHHHHHHHHHHHHHH | 12.80 | 21890473 | |
487 | Sumoylation | GTAPAQAKAEPTAAP CCCCHHHCCCCCCCC | 41.00 | - | |
487 | Acetylation | GTAPAQAKAEPTAAP CCCCHHHCCCCCCCC | 41.00 | 26051181 | |
487 | Sumoylation | GTAPAQAKAEPTAAP CCCCHHHCCCCCCCC | 41.00 | 28112733 | |
487 | Ubiquitination | GTAPAQAKAEPTAAP CCCCHHHCCCCCCCC | 41.00 | - | |
488 | Ubiquitination | TAPAQAKAEPTAAPH CCCHHHCCCCCCCCC | 30.89 | - | |
491 | O-linked_Glycosylation | AQAKAEPTAAPHPVL HHHCCCCCCCCCHHH | 27.27 | OGP | |
499 | Ubiquitination | AAPHPVLKQVIKPRR CCCCHHHHHHHCCCH | 42.63 | - | |
500 | Ubiquitination | APHPVLKQVIKPRRK CCCHHHHHHHCCCHH | 37.70 | - | |
512 | Phosphorylation | RRKLAFRSGEARDWS CHHHCCCCCCCCCCC | 34.23 | 25159151 | |
527 | Phosphorylation | NGAVLQASSQLSRGS CCCEEEECCHHCCCC | 12.98 | 18776048 | |
528 | Phosphorylation | GAVLQASSQLSRGSA CCEEEECCHHCCCCC | 37.85 | - | |
531 | Phosphorylation | LQASSQLSRGSATTP EEECCHHCCCCCCCC | 27.27 | 18776048 | |
532 | Methylation | QASSQLSRGSATTPR EECCHHCCCCCCCCC | 52.24 | - | |
534 | Phosphorylation | SSQLSRGSATTPRGV CCHHCCCCCCCCCCE | 22.72 | 21955146 | |
537 | Phosphorylation | LSRGSATTPRGVLHT HCCCCCCCCCCEEEE | 15.65 | 18776048 | |
539 | Asymmetric dimethylarginine | RGSATTPRGVLHTFS CCCCCCCCCEEEECC | 45.84 | - | |
539 | Methylation | RGSATTPRGVLHTFS CCCCCCCCCEEEECC | 45.84 | 24129315 | |
544 | Phosphorylation | TPRGVLHTFSPSPKL CCCCEEEECCCCHHH | 22.96 | 29255136 | |
546 | Phosphorylation | RGVLHTFSPSPKLQN CCEEEECCCCHHHCC | 26.14 | 29255136 | |
548 | Phosphorylation | VLHTFSPSPKLQNSA EEEECCCCHHHCCCH | 33.21 | 29255136 | |
550 | Sumoylation | HTFSPSPKLQNSASA EECCCCHHHCCCHHC | 68.02 | - | |
550 | Acetylation | HTFSPSPKLQNSASA EECCCCHHHCCCHHC | 68.02 | 26051181 | |
550 | Methylation | HTFSPSPKLQNSASA EECCCCHHHCCCHHC | 68.02 | - | |
550 | Sumoylation | HTFSPSPKLQNSASA EECCCCHHHCCCHHC | 68.02 | 28112733 | |
550 | Ubiquitination | HTFSPSPKLQNSASA EECCCCHHHCCCHHC | 68.02 | - | |
551 | Ubiquitination | TFSPSPKLQNSASAT ECCCCHHHCCCHHCH | 7.09 | - | |
554 | Phosphorylation | PSPKLQNSASATALV CCHHHCCCHHCHHHH | 15.61 | 25159151 | |
556 | Phosphorylation | PKLQNSASATALVSR HHHCCCHHCHHHHCC | 26.44 | 30576142 | |
558 | Phosphorylation | LQNSASATALVSRTG HCCCHHCHHHHCCCC | 20.30 | 23312004 | |
568 | Phosphorylation | VSRTGRHSERTVSAG HCCCCCCCEEEEECC | 27.67 | 20068231 | |
571 | Phosphorylation | TGRHSERTVSAGKGS CCCCCEEEEECCCCC | 18.11 | 20068231 | |
573 | Phosphorylation | RHSERTVSAGKGSAT CCCEEEEECCCCCCC | 30.59 | 20068231 | |
576 | Sumoylation | ERTVSAGKGSATSNW EEEEECCCCCCCCCC | 49.78 | - | |
576 | Acetylation | ERTVSAGKGSATSNW EEEEECCCCCCCCCC | 49.78 | 26051181 | |
576 | Sumoylation | ERTVSAGKGSATSNW EEEEECCCCCCCCCC | 49.78 | - | |
576 | Ubiquitination | ERTVSAGKGSATSNW EEEEECCCCCCCCCC | 49.78 | - | |
577 | Ubiquitination | RTVSAGKGSATSNWK EEEECCCCCCCCCCE | 22.92 | - | |
578 | Phosphorylation | TVSAGKGSATSNWKK EEECCCCCCCCCCEE | 31.68 | 20068231 | |
580 | Phosphorylation | SAGKGSATSNWKKTP ECCCCCCCCCCEECC | 25.04 | 20068231 | |
581 | Phosphorylation | AGKGSATSNWKKTPL CCCCCCCCCCEECCC | 40.17 | 20068231 | |
585 | Sumoylation | SATSNWKKTPLSTGG CCCCCCEECCCCCCC | 47.17 | 28112733 | |
586 | O-linked_Glycosylation | ATSNWKKTPLSTGGT CCCCCEECCCCCCCE | 26.24 | 30059200 | |
586 | Phosphorylation | ATSNWKKTPLSTGGT CCCCCEECCCCCCCE | 26.24 | 24732914 | |
589 | O-linked_Glycosylation | NWKKTPLSTGGTLAF CCEECCCCCCCEEEE | 26.64 | 30059200 | |
589 | Phosphorylation | NWKKTPLSTGGTLAF CCEECCCCCCCEEEE | 26.64 | 24732914 | |
590 | O-linked_Glycosylation | WKKTPLSTGGTLAFV CEECCCCCCCEEEEE | 47.52 | 30059200 | |
590 | Phosphorylation | WKKTPLSTGGTLAFV CEECCCCCCCEEEEE | 47.52 | 24732914 | |
593 | O-linked_Glycosylation | TPLSTGGTLAFVSPS CCCCCCCEEEEECHH | 19.09 | 30059200 | |
593 | Phosphorylation | TPLSTGGTLAFVSPS CCCCCCCEEEEECHH | 19.09 | 24732914 | |
598 | Phosphorylation | GGTLAFVSPSLAVHK CCEEEEECHHHCCCC | 11.43 | 25159151 | |
600 | Phosphorylation | TLAFVSPSLAVHKSS EEEEECHHHCCCCCC | 22.81 | 25159151 | |
605 | Sumoylation | SPSLAVHKSSSAVDR CHHHCCCCCCCCHHH | 45.49 | 28112733 | |
625 | O-linked_Glycosylation | LDMIPPRSIPQSATW HHHCCCCCCCCCCCC | 44.38 | 30059200 | |
629 | Phosphorylation | PPRSIPQSATWK--- CCCCCCCCCCCC--- | 23.47 | 24719451 | |
633 | Methylation | IPQSATWK------- CCCCCCCC------- | 46.21 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of P66A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of P66A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of P66A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RBBP4_HUMAN | RBBP4 | physical | 22939629 | |
RBBP7_HUMAN | RBBP7 | physical | 22939629 | |
K1C40_HUMAN | KRT40 | physical | 25416956 | |
CHD3_HUMAN | CHD3 | physical | 26344197 | |
MBD2_HUMAN | MBD2 | physical | 26344197 | |
MBD3_HUMAN | MBD3 | physical | 26344197 | |
MTA1_HUMAN | MTA1 | physical | 26344197 | |
RUVB1_HUMAN | RUVBL1 | physical | 26344197 | |
CHD5_HUMAN | CHD5 | physical | 28514442 | |
HDAC1_HUMAN | HDAC1 | physical | 28514442 | |
CHD3_HUMAN | CHD3 | physical | 28514442 | |
PKCB1_HUMAN | ZMYND8 | physical | 28514442 | |
ZN592_HUMAN | ZNF592 | physical | 28514442 | |
MBD2_HUMAN | MBD2 | physical | 28514442 | |
MTA3_HUMAN | MTA3 | physical | 28514442 | |
ZN687_HUMAN | ZNF687 | physical | 28514442 | |
CHD4_HUMAN | CHD4 | physical | 28514442 | |
MBD3_HUMAN | MBD3 | physical | 28514442 | |
MTA1_HUMAN | MTA1 | physical | 28514442 | |
MTA2_HUMAN | MTA2 | physical | 28514442 | |
CDKA1_HUMAN | CDK2AP1 | physical | 28514442 | |
APBP2_HUMAN | APPBP2 | physical | 28514442 | |
RBBP4_HUMAN | RBBP4 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-49; SER-100; SER-107;SER-114; THR-189 AND SER-340, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100; SER-107; SER-114AND SER-340, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-49; SER-100; SER-107;SER-114; SER-340; SER-546; SER-548 AND SER-598, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-49; SER-100; SER-107;SER-113 AND SER-114, AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546 AND SER-598, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100; SER-107 ANDSER-114, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-189, AND MASSSPECTROMETRY. |